[Rare pancreatic endocrine tumors].
Functional pancreatic endocrine tumors other than gastrinoma and insulinoma are quite rare. Some of these tumors may be part of multiple endocrine neoplasia type one (MEN-1) syndrome or phakomatoses. Depending on their cell type, functional pancreatic endocrine tumors may cause distinct clinical endocrine syndromes, such as the 'glucagonoma syndrome', Verner-Morrison syndrome and the 'somatostatinoma syndrome'. The significant progress made in recent years, especially in the field of imaging procedures, has brought about great improvement in the identification and differentiation of these neoplasms. Currently, the only curative treatment for islet cell tumors is complete surgical resection. The medical treatment of endocrine pancreatic tumours consists of somatostatin analogues, chemotherapy, and interferon-alpha. The purpose of this manuscript is to provide an overview of the contemporary etiopathogenesis, diagnosis and treatment of rare pancreatic endocrine tumors.
Krysiak
Robert
R
Klinika Chorób Wewnetrznych i Farmakologii Klinicznej, Slaski Uniwersytet Medyczny, Katowice. r.krysiak@pharmanet.com.pl
Okopień
Bogustław
B
Herman
Zbigniew Stanisław
ZS
D005935:Glucagonoma / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D035583:Rare Diseases / Q000175:diagnosis / Q000628:therapy; D013005:Somatostatinoma / Q000175:diagnosis* / Q000628:therapy*; D003969:Vipoma / Q000175:diagnosis* / Q000628:therapy*